-PTI Expressing concern over price rise in fruit and vegetables, the government today said it will focus on addressing the issue by bringing more area under horticulture as well as raising productivity levels. "We are more or less comfortable in cereal production. The growth rate in horticultural and animal products is good and better than cereals. But we see price rise in horticulture commodities. This is the area of concern," Agriculture Secretary...
More »SEARCH RESULT
Total Matching Records found : 1018
A historic move to make drugs affordable-G Ananthakrishnan
India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...
More »Fertiliser subsidy bill for the current fiscal set to cross Rs 70,000 crore by Deepshikha Sikarwar
The government is likely to peg fertiliser subsidy for next financial year at Rs 66,000 crore, lower than the actual outgo in 2011-12. "A moderate increase is likely," said a government official. The actual subsidy bill for the fiscal is likely to come at over Rs 70,000 crore though the government had budgeted for just Rs 49,997 crore in the budget 2011-12. Private analysts had soon after the presentation of the last...
More »Agri report calls for growth on a par with GDP by Sandip Das
A report on ‘State of Indian Agriculture 2011-12’, tabled in the Lok Sabha on Tuesday, has called for reforms to ensure that the sector grows in tandem with the overall GDP of the country. The report says that “achieving an 8-9% rate of growth in the overall GDP may not deliver much in terms of poverty reduction unless agricultural growth accelerates”. Admitting that the sector has undergone ‘significant structural changes’ in...
More »AIDAN proposes another pricing model for essential drugs by Khomba Singh
A non-government organisation campaigning for cheaper essential drugs has proposed an alternative pricing model that seeks to fix Retail prices at the average price of all brands in a segment. The proposal of the All India Drug Action Network (AIDAN) is being examined by the department of pharmaceuticals (DoP), an official said. AIDAN says its new pricing mechanism, which excludes brands that account for the top 20% by sales, will make...
More »
